Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Urshita Sinha"'
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 545-550 (2021)
Abstract Tyrosine kinase inhibitors (TKIs) are the key agents for treating CML and BCR–ABL+ B‐ALL. Dasatinib is a potent second‐generation TKI. Here, we have discussed the case of a 51‐year‐old gentleman diagnosed with B‐myeloid mixed‐p
Externí odkaz:
https://doaj.org/article/5198a8586307400a835a742016deebde
Publikováno v:
European Journal of Clinical Investigation